Hosted on MSN13d
Zimmer Biomet’s total knee implant component gains FDA 510(k) clearance
Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, ...
MarketWatch23d
Zimmer Biomet's Oxford Cementless Partial Knee Approved by FDA
Medical technology company Zimmer Biomet has received approval from the U.S. Food and Drug Administration for its Oxford cementless partial knee, making it the first implant of its kind available ...
FierceBiotech15d
Zimmer Biomet's knee implants collect FDA green lights as cementless alternatives
Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...
Zacks.com on MSN14d
ZBH Stock Might Rise Following FDA Nod for Knee Implant Component
Zimmer Biomet Holdings, Inc. ZBH recently received the FDA 510(k) clearance for its Persona SoluTion Porous Plasma Spray ...
Morningstar23d
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
the Oxford Cementless Partial Knee has become the preferred partial knee implant for Zimmer Biomet's European customers.5 As part of the U.S. nationwide launch in Q1 2025, Zimmer Biomet will ...
Morningstar1mon
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System.
Nasdaq1mon
Zimmer Biomet announces CE Mark certification for knee system
Zimmer Biomet (ZBH) received the CE Mark for its Persona Revision Knee System. This addition to the Persona family builds on Zimmer Biomet’s commitment to personalized solutions, providing ...